Mimedx (MDXG) Accumulated Depreciation & Amortization (2011 - 2026)

Mimedx's Accumulated Depreciation & Amortization history runs 16 years deep, the most recent figure standing at $23.9 million for Q1 2026.

• In Q1 2026, Accumulated Depreciation & Amortization rose 9.09% year-over-year to $23.9 million; the TTM figure through Mar 2026 stood at $23.9 million (up 9.09% YoY), while the FY2025 annual figure was $23.5 million, up 10.21% from the prior year.
• Accumulated Depreciation & Amortization came in at $23.9 million for Q1 2026 at Mimedx, up from $23.5 million in the prior quarter.
• In the past five years, Accumulated Depreciation & Amortization ranged from a high of $37.9 million in Q3 2023 to a low of $20.0 million in Q4 2023.
• A 5-year average of $27.6 million and a median of $23.5 million in 2025 frame the typical range for Accumulated Depreciation & Amortization.
• Across the five-year window, Accumulated Depreciation & Amortization advanced 11.31% in 2022 and slumped 44.25% in 2023, its largest moves.
• Mimedx's Accumulated Depreciation & Amortization stood at $35.9 million in 2022, then plunged by 44.25% to $20.0 million in 2023, then grew by 6.46% to $21.3 million in 2024, then rose by 10.21% to $23.5 million in 2025, then increased by 1.54% to $23.9 million in 2026.
• According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods registered $23.9 million, $23.5 million, and $23.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison